Tripchlorolide induces autophagy in lung cancer cells by inhibiting the PI3K/AKT/mTOR pathway and improves cisplatin sensitivity in A549/DDP cells.
Tripchlorolide induces autophagy in lung cancer cells by inhibiting the PI3K/AKT/mTOR pathway and improves cisplatin sensitivity in A549/DDP cells.
复制标题
三氯内酯通过抑制 PI3K/AKT/mTOR 通路诱导肺癌细胞自噬并提高 A549/DDP 细胞对顺铂的敏感性
DOI:
10.18632/oncotarget.19201
复制
发表时间:
2017-09-08
期刊:
影响因子:
--
通讯作者:
Lin TY
中科院分区:
文献类型:
--
作者:
Chen LM;Song TJ;Xiao JH;Huang ZH;Li Y;Lin TY
Tripchlorolide (T4) has been shown to induce A549 lung cancer cell death predominantly by activating an autophagy pathway. However, the underlying mechanism remains unclear. Herein, we demonstrated that compared with T4 treatment alone, pretreatment with wortmannin (an inhibitor of phosphatidylinositol 3-kinase), perifosine (an inhibitor of AKT) or rapamycin (an inhibitor of mTOR) combined with a subsequent T4 treatment significantly impaired the cell viability of A549 and A549/DDP lung cancer cells. We found that either treatment scheme markedly reduced the activity of P13K and AKT. Expression of LC3II increased in parallel to the increase of the T4 concentration in both A549 and A549/DDP cells and was repressed by overexpression of AKT. The expression levels of PI3-K, PI3-P, AKT, TSC2, mTOR, p70S6K and 4E-BP1 were minimally affected by the wortmannin, perifosine, or rapamycin plus T4 treatments, but their phosphorylated products were greatly affected in A549 lung cancer cells and slightly affected in A549/DDP lung cancer cells. These results indicate that T4 induces autophagy in lung cancer cells by inhibiting the PI3K/AKT/mTOR signaling pathway. We further found that T4 decreased expression of MDR1 and improved cisplatin sensitivity of A549/DDP cells. Altogether, these results have meaningful implications for tumor therapy in the future.
登录
查看更多内容
影响因子:
5.5
作者:
Zheng HY;Zhang XY;Wang XF;Sun BC
通讯作者:
Sun BC
影响因子:
5.2
作者:
Kaewpiboon, Chutima;Surapinit, Serm;Chung, Young-hwa
通讯作者:
Chung, Young-hwa
影响因子:
4.2
作者:
Cho, Kyung-Hwa;Park, Ji-Hye;Yang, Sei-Hoon
通讯作者:
Yang, Sei-Hoon
影响因子:
8
作者:
Veldhoen, R. A.;Banman, S. L.;Goping, I. S.
通讯作者:
Goping, I. S.
DOI:
10.2147/dddt.s69690
发表时间:
2014
期刊:
Drug design, development and therapy
影响因子:
--
作者:
Fang S;Wang Z
通讯作者:
Wang Z